Clarus Therapeutics, Inc.   Report issue

For profit Phase 2 Phase 4
Founded: Northbrook IL United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2007
NCT02697188
First Marketed Drug
2019
testosterone (delatestryl)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Claris Biotherapeutics, Inc. | CLARUS | Clarus Therapeutics | Clarus Therapeutics, Inc. | CLARUS THERAPEUTICS INC